Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.9295 |
High Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.9125 |
High Similarity |
NPD6959 |
Discontinued |
0.8841 |
High Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.875 |
High Similarity |
NPD7819 |
Suspended |
0.875 |
High Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.8718 |
High Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.8642 |
High Similarity |
NPD7768 |
Phase 2 |
0.8625 |
High Similarity |
NPD7411 |
Suspended |
0.8614 |
High Similarity |
NPD6166 |
Phase 2 |
0.8614 |
High Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.8614 |
High Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.8599 |
High Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.8562 |
High Similarity |
NPD4380 |
Phase 2 |
0.8506 |
High Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.8506 |
High Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.8485 |
Intermediate Similarity |
NPD5494 |
Approved |
0.8476 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.8462 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.8457 |
Intermediate Similarity |
NPD1934 |
Approved |
0.8452 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.8364 |
Intermediate Similarity |
NPD3749 |
Approved |
0.8304 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.8293 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.8253 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.8246 |
Intermediate Similarity |
NPD7054 |
Approved |
0.8235 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.8208 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.8205 |
Intermediate Similarity |
NPD2796 |
Approved |
0.8198 |
Intermediate Similarity |
NPD7472 |
Approved |
0.8193 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.8187 |
Intermediate Similarity |
NPD7390 |
Discontinued |
0.8161 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.815 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.8141 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.8114 |
Intermediate Similarity |
NPD8313 |
Approved |
0.8114 |
Intermediate Similarity |
NPD8312 |
Approved |
0.8103 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.8084 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.8081 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.8075 |
Intermediate Similarity |
NPD1511 |
Approved |
0.8072 |
Intermediate Similarity |
NPD2801 |
Approved |
0.8059 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.805 |
Intermediate Similarity |
NPD2800 |
Approved |
0.8046 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.8035 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.8025 |
Intermediate Similarity |
NPD2532 |
Approved |
0.8025 |
Intermediate Similarity |
NPD2534 |
Approved |
0.8025 |
Intermediate Similarity |
NPD2533 |
Approved |
0.8012 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.8 |
Intermediate Similarity |
NPD1240 |
Approved |
0.8 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.7987 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.7975 |
Intermediate Similarity |
NPD1512 |
Approved |
0.7937 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7917 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.7898 |
Intermediate Similarity |
NPD1607 |
Approved |
0.7875 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.7862 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7862 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7857 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.7853 |
Intermediate Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.7805 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.779 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.7785 |
Intermediate Similarity |
NPD6651 |
Approved |
0.7778 |
Intermediate Similarity |
NPD3750 |
Approved |
0.7753 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.7751 |
Intermediate Similarity |
NPD8455 |
Phase 2 |
0.775 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7746 |
Intermediate Similarity |
NPD7229 |
Phase 3 |
0.7744 |
Intermediate Similarity |
NPD6799 |
Approved |
0.7725 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7711 |
Intermediate Similarity |
NPD920 |
Approved |
0.7706 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7702 |
Intermediate Similarity |
NPD2344 |
Approved |
0.7679 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.7669 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7643 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7632 |
Intermediate Similarity |
NPD7870 |
Phase 2 |
0.7632 |
Intermediate Similarity |
NPD7871 |
Phase 2 |
0.7624 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7622 |
Intermediate Similarity |
NPD4363 |
Phase 3 |
0.7622 |
Intermediate Similarity |
NPD4360 |
Phase 2 |
0.7619 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.7607 |
Intermediate Similarity |
NPD1243 |
Approved |
0.7605 |
Intermediate Similarity |
NPD5403 |
Approved |
0.76 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.759 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.7582 |
Intermediate Similarity |
NPD8150 |
Discontinued |
0.7579 |
Intermediate Similarity |
NPD7698 |
Approved |
0.7579 |
Intermediate Similarity |
NPD7697 |
Approved |
0.7579 |
Intermediate Similarity |
NPD7696 |
Phase 3 |
0.7578 |
Intermediate Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.7578 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.7576 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.7565 |
Intermediate Similarity |
NPD8151 |
Discontinued |
0.7543 |
Intermediate Similarity |
NPD5710 |
Approved |
0.7543 |
Intermediate Similarity |
NPD5711 |
Approved |
0.7543 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7542 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.754 |
Intermediate Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.7531 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.7528 |
Intermediate Similarity |
NPD7286 |
Phase 2 |
0.7515 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7515 |
Intermediate Similarity |
NPD2309 |
Approved |
0.7513 |
Intermediate Similarity |
NPD6782 |
Approved |
0.7513 |
Intermediate Similarity |
NPD6777 |
Approved |
0.7513 |
Intermediate Similarity |
NPD6779 |
Approved |
0.7513 |
Intermediate Similarity |
NPD6778 |
Approved |
0.7513 |
Intermediate Similarity |
NPD6776 |
Approved |
0.7513 |
Intermediate Similarity |
NPD6780 |
Approved |
0.7513 |
Intermediate Similarity |
NPD6781 |
Approved |
0.75 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7487 |
Intermediate Similarity |
NPD7782 |
Clinical (unspecified phase) |
0.7487 |
Intermediate Similarity |
NPD7783 |
Phase 2 |
0.7487 |
Intermediate Similarity |
NPD7435 |
Discontinued |
0.7486 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.7486 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7486 |
Intermediate Similarity |
NPD1247 |
Approved |
0.7485 |
Intermediate Similarity |
NPD5401 |
Approved |
0.7485 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.7472 |
Intermediate Similarity |
NPD7228 |
Approved |
0.7472 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.7471 |
Intermediate Similarity |
NPD919 |
Approved |
0.7469 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7442 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7442 |
Intermediate Similarity |
NPD5760 |
Phase 2 |
0.7442 |
Intermediate Similarity |
NPD5761 |
Phase 2 |
0.7427 |
Intermediate Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.7423 |
Intermediate Similarity |
NPD7701 |
Phase 2 |
0.7423 |
Intermediate Similarity |
NPD5406 |
Approved |
0.7423 |
Intermediate Similarity |
NPD5408 |
Approved |
0.7423 |
Intermediate Similarity |
NPD5404 |
Approved |
0.7423 |
Intermediate Similarity |
NPD5405 |
Approved |
0.7405 |
Intermediate Similarity |
NPD4287 |
Approved |
0.7403 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.7401 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7398 |
Intermediate Similarity |
NPD7801 |
Approved |
0.7394 |
Intermediate Similarity |
NPD4361 |
Phase 2 |
0.7394 |
Intermediate Similarity |
NPD4362 |
Clinical (unspecified phase) |
0.7391 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.7391 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.7384 |
Intermediate Similarity |
NPD37 |
Approved |
0.7381 |
Intermediate Similarity |
NPD7422 |
Clinical (unspecified phase) |
0.7371 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7362 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7358 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.7356 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7356 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7356 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7349 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7349 |
Intermediate Similarity |
NPD7003 |
Approved |
0.7347 |
Intermediate Similarity |
NPD7874 |
Approved |
0.7347 |
Intermediate Similarity |
NPD7875 |
Clinical (unspecified phase) |
0.7344 |
Intermediate Similarity |
NPD6823 |
Phase 2 |
0.7342 |
Intermediate Similarity |
NPD2861 |
Phase 2 |
0.7337 |
Intermediate Similarity |
NPD6273 |
Approved |
0.733 |
Intermediate Similarity |
NPD7501 |
Clinical (unspecified phase) |
0.7316 |
Intermediate Similarity |
NPD7699 |
Phase 2 |
0.7316 |
Intermediate Similarity |
NPD7700 |
Phase 2 |
0.7312 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.7312 |
Intermediate Similarity |
NPD6410 |
Clinical (unspecified phase) |
0.7296 |
Intermediate Similarity |
NPD6832 |
Phase 2 |
0.729 |
Intermediate Similarity |
NPD1547 |
Clinical (unspecified phase) |
0.7282 |
Intermediate Similarity |
NPD7584 |
Approved |
0.7278 |
Intermediate Similarity |
NPD7177 |
Discontinued |
0.7278 |
Intermediate Similarity |
NPD7893 |
Clinical (unspecified phase) |
0.7273 |
Intermediate Similarity |
NPD2343 |
Clinical (unspecified phase) |
0.7268 |
Intermediate Similarity |
NPD8319 |
Approved |
0.7268 |
Intermediate Similarity |
NPD8320 |
Phase 1 |
0.7249 |
Intermediate Similarity |
NPD6534 |
Approved |
0.7249 |
Intermediate Similarity |
NPD6535 |
Approved |
0.7246 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.7222 |
Intermediate Similarity |
NPD1613 |
Approved |
0.7222 |
Intermediate Similarity |
NPD943 |
Approved |
0.7222 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.7219 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7213 |
Intermediate Similarity |
NPD7685 |
Pre-registration |
0.7205 |
Intermediate Similarity |
NPD3268 |
Approved |
0.7205 |
Intermediate Similarity |
NPD3764 |
Approved |
0.7197 |
Intermediate Similarity |
NPD4749 |
Approved |
0.7195 |
Intermediate Similarity |
NPD7097 |
Phase 1 |
0.7191 |
Intermediate Similarity |
NPD8127 |
Discontinued |
0.7184 |
Intermediate Similarity |
NPD7577 |
Discontinued |
0.7184 |
Intermediate Similarity |
NPD6844 |
Discontinued |
0.717 |
Intermediate Similarity |
NPD2798 |
Approved |
0.7134 |
Intermediate Similarity |
NPD1608 |
Approved |
0.712 |
Intermediate Similarity |
NPD7240 |
Approved |
0.7107 |
Intermediate Similarity |
NPD2797 |
Approved |
0.7107 |
Intermediate Similarity |
NPD1203 |
Approved |
0.7104 |
Intermediate Similarity |
NPD1729 |
Discontinued |
0.7098 |
Intermediate Similarity |
NPD8285 |
Discontinued |
0.7083 |
Intermediate Similarity |
NPD2654 |
Approved |
0.7081 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.7076 |
Intermediate Similarity |
NPD7447 |
Phase 1 |
0.7073 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.7073 |
Intermediate Similarity |
NPD8155 |
Clinical (unspecified phase) |
0.7073 |
Intermediate Similarity |
NPD1899 |
Clinical (unspecified phase) |
0.7072 |
Intermediate Similarity |
NPD2403 |
Approved |
0.707 |
Intermediate Similarity |
NPD1201 |
Approved |
0.7066
|
Intermediate Similarity |
NPD6004 |
Phase 3 |